Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content
Condition(s):Gender Dysphoria; Hormone Therapy Induced Morphologic ChangeLast Updated:March 4, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Gender Dysphoria; Hormone Therapy Induced Morphologic ChangeLast Updated:March 4, 2024Recruiting
Condition(s):Gender DysphoriaLast Updated:January 10, 2024Recruiting
Condition(s):Hormonal Gender-Affirming TherapyLast Updated:March 21, 2023Recruiting
Condition(s):Postoperative Hematoma; Postoperative SeromaLast Updated:November 18, 2023Recruiting
Condition(s):Transgender; Gender IncongruenceLast Updated:November 18, 2023Recruiting
Condition(s):Knowledge, Attitudes, PracticeLast Updated:January 5, 2023Recruiting
Condition(s):Gender DysphoriaLast Updated:May 18, 2023Recruiting
Condition(s):TransgenderismLast Updated:December 5, 2022Recruiting
Condition(s):Transgender PersonsLast Updated:March 21, 2024Recruiting
Condition(s):Transgender Women; HIV/AIDS; Cardiovascular Diseases; Metabolic Disease; CoagulopathyLast Updated:February 16, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.